IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Obsessive-Compulsive Disorder
Uppsala University Hospitalmonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Obsessive-Compulsive Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOXETINE Massachusetts General Hospital | Phase 4 | BB |
Cipralex BeerYaakov Mental Health Center | Phase 4 | BB |
Sertraline Yang I. Pachankis, PhD | Phase 4 | BB |
Clomipramine National Center for Research Resources (NCRR) | Phase 2 | CCC |
Paroxetine Beijing Tongren Hospital | Phase 1 | CC |
View all 10 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →